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PICOT: In adult patients undergoing procedural sedation, how does the administration of Ketofol 
compared with Propofol alone affect adverse respiratory effects within the perioperative period? 
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Procedural Sedation and Medications  
 Coming to the hospital in any fashion can be an anxiety ridden and a potentially painful 
experience for our patients. The most common reasons for Emergency Department and hospital 
visits for adults ages 18-85+ were open wounds of the head, neck, trunk, and extremities, chest 
pain and cardiac issues, asthma exacerbations, and sprains and strains, in which most instances, 
these cases resulted in discharge after treatment (Weiss, Wier, Stocks, & Blanchard, 2006). 
There are many uncomfortable and unpleasant procedures that can take place within the hospital 
whether you are in the emergency department, intensive care units, or even general medicine 
floors. Some of these procedures can include cardioversion, orthopedic injury reduction, and 
even a bronchoscopy (Adams, Dervay, Alexander, & Susla, 2012). With the thought of having a 
procedure done, this can cause anxiety, pain, and agitation for the patient and as a care provider, 
the goal is to minimize these behaviors that patients exhibit and experience. Currently, one of the 
best ways to accomplish this goal is by acting with procedural sedation. Procedural sedation, 
which was previously known as conscious sedation, is defined as “a technique of administering 
sedatives or dissociative agents with or without analgesics to induce a state that allows patients 
to tolerate unpleasant procedures while maintaining cardiorespiratory function” (Adams et al., 
2012).  
 With the variety of different medications available to be used in the procedural sedation 
and analgesia (PSA) setting, there are multiple adverse effects, pharmacological distinctions, and 
functions that can be of use to the provider. When it comes to what makes a great PSA 
pharmacological agent, there a few considerations. The agent must allow the patient to be subject 
to minimal anxiety, pain, and discomfort while experiencing maximal amnesia during the 
procedure. To maximize procedural timeliness, procedural sedation and analgesia agents should 
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have a rapid onset of action, short duration of action, and an ease of administration (Deady, 
Smith, & Kuhn, 2007). The most commonly used agents include propofol, benzodiazepines, 
ketamine, opioids, and etomidate. The varying onset and action times is what helps to determine 
which medication will be used. Most importantly, the sedative, analgesic, and dissociative effects 
such as hemodynamic changes and respiratory depression should be closely monitored (Adams 
et al., 2012). With the objective of identifying whether Ketofol or propofol alone creates more 
adverse respiratory effects for those undergoing procedural sedation, it is imperative to examine 
and understand the inner workings of these medications and their characteristics.  
Anesthetics- Receptors and Neurotransmitters 
  Anesthesia refers to the practice of blocking the feeling of pain to allow medical and 
surgical procedures to be undertaken without pain. Before anesthesia methods were discovered, 
opium and alcohol were regularly used to produce insensibility, both of which had a number of 
negative side effects and did not dull the pain completely (History of Anesthesia, n.d.). Patients 
were often held or tied down, and few procedures were possible as speed was the main 
determinant of a successful surgeon. Due to the lack of sedation and their painful nature, 
surgeries or procedures were an absolute last resort.  
 With the creation and findings of vapors, gases, and medications, we are now able to 
perform these procedures with more ease than was experienced hundreds of years ago. We are 
now able to provide a better procedural experience for the patient; doctors are allotted more time 
during surgery to complete their refined and complex skills.  
 As of recently, we have been able to figure out how anesthetics work. Scientists are now 
able to study how drugs affect specific molecules within cells. It has been discovered that these 
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drugs target proteins in the membranes around nerve cells (Anesthesia, 2020). Some of the 
available agents used for procedural sedation mimic the activity of gamma-aminobutyric acid 
(GABA), which is an inhibitory neurotransmitter (Adams et al., 2012). Since GABA acts in the 
central nervous system, it functions to reduce the activity of the neurons it binds. It essentially 
inhibits nerve transmission in the brain, which calms nervous activity (Zanetti, n.d.). Within the 
GABA receptors, there are two types known as GABA-A and GABA-B. General anesthetics and 
benzodiazepines typically act on GABA-A, as it is associated with a chloride ion channel. By 
activating these receptors, this causes hyperpolarization of the neuron, which results in sedation, 
anxiolysis, and hypnosis (Adams et al., 2012).  
 However, not all anesthetics function on the GABA receptors and neurons. Some agents, 
one being ketamine, works by inhibiting N-methyl- D-aspartate (NMDA) receptors that are 
found throughout the central nervous system as well. When these receptors are activated by 
excitatory neurotransmitters, such as glutamate, an influx of calcium enters the neuron resulting 
in excitation. By inhibiting these receptors, this prevents the excitation and results in a sedative 
and dissociative effect (Adams et al., 2012). 
Ketamine 
 While ketamine has been around for quite some time, it is just now making an appearance 
to the forefront of procedural sedation and analgesia. When referring to its neurotransmitters and 
receptors, ketamine is very effective. Ketamine is an NMDA receptor blocker that inhibits the 
binding of glutamate (Adams et al., 2012). Ketamine is an agent that provides excellent 
anesthetic induction and maintenance. It causes a dissociation between the cortical and limbic 
systems and prevents patients from perceiving sensory stimuli (Ghojazadeh, Sanaie, Paknezhad, 
Faghih, & Soleimanpour, 2019). While it is a great amnestic and analgesic agent, it helps to 
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preserve airway reflexes, cardiovascular and respiratory stimulation, and analgesia. Ketamine 
has a rapid onset of action but has a longer half-life compared to other sedative agents (Adams et 
al., 2012). However, the use of ketamine alone is limited  due to longer recovery time, and the 
potential side effects of agitation and vomiting (Andolfatto & Willman, 2011). It is important to 
note, that ketamine could be a good analgesic for a patient who is hypotensive, as a dose of 
ketamine is shown to increase heart rate and blood pressure, but not affect respiratory function 
(Adams et al., 2012). Ketamine is a great agent to combine with other sedative medications as 
most sedatives do tend to lower the heart rate and blood pressure on their own.  
Propofol 
 As a long standing and well known sedation agent, propofol is a consistent procedural 
sedation agent that many providers and personnel will turn to due to its effects and 
characteristics. Looking at its receptors and chemical make-up, propofol is a short acting 
alkylphenol that is used to induce and maintain anesthesia while also sedating patients for 
procedure. Due to the discovery of propofol in 1975, the use has now been more common and 
has benefitted the medical world immensely. . From the chemical model of this agent, we can see 
how efficiently it works due to its agonist properties on the GABA and NMDA receptors which 
causes a huge pain reduction (Ghojazadeh et al., 2019). Propofol also suppresses sympathetic 
activity and inhibits the baroreceptor reflex, which is what could cause a drop in blood pressure 
and heart rate (Kanaya, Hirata, Kurosawa, Nakayama, & Namiki, 2003). While propofol does 
facilitate a sedation and amnesia effect, the lack of an analgesic property makes this agent one 
that works better when in combination with another medication that can make up for the missing 
pieces. Due to the fast onset of action and short duration of action, this is an ideal agent for short 
procedures and a quicker recovery time (Adams et al., 2012). However, propofol does include a 
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few adverse effects, some of which include respiratory depression and hypotension. Since there 
is that potential of negative effects, the dosing of propofol is typically given slower so that less 
hemodynamic changes are observed. 
Ketofol 
 Since medicine is lacking a drug that provides all benefits of a great procedural sedation 
analgesic, a combination of dissociative, sedative, and analgesic agents are used together to 
create the desired effects. When the combination of ketamine and propofol are used in 
conjunction to create Ketofol, they are mixed into a single syringe which reduces the required 
doses of each individual agent. The use of both agents potentially mitigates the risk of adverse 
respiratory events compared to propofol alone or in combination with opioids. By adding 
ketamine to propofol, the potential for hemodynamic instability is reduced while still providing 
deep sedation and analgesia to patients (Yan, Mcleod, & Iansavitchene, 2015). While ketamine 
may bring on feelings of nausea, vomiting, and agitation after a procedure, propofol has 
antiemetic and anxiolytic properties to combat the side effects of ketamine (Smith, Monk, White, 
& Ding, 1994). It has also been noted these two agents are physically compatible and chemically 
stable when mixed in syringes and stored at room temperature with light exposure (Andolfatto et 
al., 2011). In an effort to balance the hemodynamic adverse effects, the combination is usually 
dosed at a 1:1 ratio.  
Acquisition of External Evidence 
 As the world of medicine and the use of anesthetics are constantly evolving, it seems 
pertinent to discuss the data pertaining to this topic of the use of Ketofol versus Propofol for 
adults undergoing procedural sedation. Having met with a librarian for a previous paper, I was 
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able to apply the same ideals and principles for solidifying my topic by using searches that would 
return the most reflective and applicable data available to my research. To find the necessary 
data, I utilized databases such as  PUBMED, National Center for Biotechnology Information 
(NCBI), the American Journal of Emergency Medicine, Society for Academic Emergency 
Medicine, and Cumulative Index to Nursing and Allied Health Literature (CINAHL). These 
databases provided me with health science relevant sources from a multitude of different 
disciplines. Key terms that were utilized included: “propofol, ketamine, Ketofol, procedural 
sedation, conscious sedation, respiratory.” In conjunction with key terms, I used key phrases 
which included: “propofol and ketamine, Ketofol and propofol, Ketofol and procedural sedation, 
Ketofol and conscious sedation, propofol versus Ketofol, and propofol and procedural sedation.” 
I was then able to narrow down the search criteria to compare these medication uses in a 
procedural sedation setting to give me focused articles. 
 From these results, the PICOT question was refined in order to reflect the current and 
available data to create a well-rounded evidence based recommendation. I did some further 
evaluation of all internal and external factors of the sources including sample size, selection 
criteria, length, and any potential confounding variables. There was also a higher precedence to 
use systematic reviews and meta-analyses as they helped to ensure high standards of evaluating 
the study at hand.  
Summary of External Evidence 
 There were various sources that were used to gather data on which sedation medications 
were more effective at producing less adverse respiratory effects for adults undergoing 
procedural sedation. A systematic review done by Yan et al. (2015) utilized  six different 
randomized control trials that had a primary objective of determining if Ketofol has a lower 
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frequency of adverse respiratory effects in patients undergoing PSA than propofol alone. This 
systematic review presents high levels of evidence, a large sample size (932 total patients 
reported on: 520 given Ketofol, 412 given propofol), and the results of each study were reported 
clearly with the use of tables and charts. Additionally, in all of the studies, there was reported 
times for sedation, procedure, and recovery. However, only five of the six RCTs reported on 
adverse events, but out of the five that did, they were able to see what events were reported as 
the same. Some weaknesses or limitations included that not all six of the RCTs were limited to 
just adults, some trials had different methods that were used (i.e., randomized, blind), and there 
was some heterogeneity with the doses and ratios of Ketofol used. The systematic review did 
conclude that Ketofol had a lower incidence of adverse respiratory events when compared to 
propofol alone (29% vs. 35.4%), which shows statistical significance.  
 A clinical trial performed by Miner et al. (2014) compared the frequency of airway and 
respiratory adverse events leading to an intervention between propofol with a 1:1 ratio and a 1:1 
propofol: ketamine or 4:1 mixture of propofol: ketamine in a randomized, double blind 
experiment. This experiment went from October 2010 to February 2013 in which there were 271 
patients randomized to three groups: Propofol only had 90 patients, 1:1 Ketofol had 85 patients, 
and 4:1 Ketofol had 96 patients. All three groups received an initial sedative bolus of 0.1mL/kg. 
Additionally, this experiment did a great job in the areas of randomization, providing a large 
sample size, and enrolling only adults. Individuals who had a hypersensitivity to either 
medication, who were pregnant, showed signs of intoxication, or had an American Society of 
Anesthesiologists physical status greater than two were disqualified. The main 
weakness/limitation of this trial was that many patients had clinical interventions but not an 
airway or respiratory adverse event, indicating that clinicians responded to a subtle cue to 
KETOFOL VERSUS PROPOFOL IN PROCEDURAL SEDATION 9 
 
intervene before an adverse event happened, which could make it hard to detect these factors 
between the groups. Additionally, all the individuals in this trial were sampled from one facility. 
The study concluded that their primary outcome was similar between groups and they did not 
detect a difference in the frequency of adverse airway or respiratory events leading to 
intervention between a 1:1 (19%) or 4:1 (32%) combination of propofol and ketamine relative to 
propofol alone (29%). Therefore, this study deems each combination of medication to appear 
similarly safe and effective by resulting in a p value of p = 0.21.  
 A systematic review done by Jalili et al. (2015) used the data and information from 18 
randomized control trials to meet their objective of evaluating the analgesic and side effects of 
the ketamine-propofol combination (Ketofol) in comparison to propofol in procedural sedation 
and analgesia (PSA). This study sufficiently outlined did a great job of outlining their criteria 
while sorting through a large amount of articles. A strength of this review was that they used the 
Jadad quality score, in which all articles used had a score of at least 3. The score came from a 
combination of randomization, blinding, and dropouts to which it was given a score on whether 
or not it was present or described appropriately. However, the main weakness identified in this 
review was the heterogeneity that was present in each individual review as there was variance 
between the procedures being performed, settings, and doses of Ketofol that were used. To 
combat the heterogeneity that was calculated, the random effect was applied for risk ratio 
calculations. With the risk ratio in effect, this yielded a statistically significant result for Ketofol 
being a more effective choice than propofol for reducing respiratory adverse events. This was 
presented in a clearly laid out table showing that out of all the RCTs used, Ketofol had 6% of 
patients experience an incidence, while propofol had 11% of the patients experience an incident. 
In conjunction of applying the random effect, it was shown that Ketofol lowered the incidence of 
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cardiovascular issues such as hypotension and bradycardia as well. Overall, the study supports 
the use of ketamine-propofol as an effective combination in reducing many complications, and 
the authors recommend Ketofol as an appropriate substitution for propofol.  
 Ferguson et al. (2016) put out a successful great randomized double-blinded clinical trial 
whose primary outcome was to determine whether physicians providing deep sedation with 1:1 
Ketofol versus propofol results in fewer adverse respiratory events requiring physician 
intervention when used for procedural sedation and analgesia. A major strength is the sample 
size and those they chose to enroll in this study. They enrolled patients aged 18 years or older, 
who required deep procedural sedation. Patients were excluded if they were unable to provide 
consent, were pregnant, allergic to the medications, had uncontrolled hypertension, or a reduced 
level of consciousness. These parameters allow researchers to base each individual from the 
same baseline. I also think the fact that this was a randomized double-blind clinical trial speaks 
volumes to the mechanics of this study. However, while their study was rather large (573 
patients), they did have some limitations. There may have been some selection bias as they had 
recruited a convenience sample and there were definite staffing limitations. Due to the required 
staff and mandated ER physician for the procedure, they could not recruit as many people for 
this study which could have affected them at times when the ER was very busy. There could 
have also been some confounding variables in the study since they did not control preprocedural 
opiate use or prophylactic oxygen delivery. In terms of primary outcomes, they were looking at 
the occurrence of a respiratory event, defined as hypoxia (SpO2 < 93%), hypoventilation (RR < 
8 breaths/min), apnea, aspiration, and the occurrence of a rescue intervention (increased O2 flow, 
airway repositioning). When comparing the two groups, the occurrence was similar, with the 
exception of the propofol group more frequently needing bag-valve-mask ventilation. In 
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conclusion, the authors stated that while propofol had a slightly higher incidence of causing 
hypotension, that procedural sedation using Ketofol versus propofol alone results in similar 
frequency of adverse respiratory events requiring intervention.  
Clinical Practice Recommendations 
 As a nurse, there are many different roles involving patient care, one of which includes 
being an advocate for patient safety and satisfaction. Even though nurses are not the ones to 
perform the procedural sedation procedure, they are typically there during the procedure and can 
suggest the use of different medications as an appropriate alternative to the more commonly used 
ones. Procedural sedations are used frequently for a variety of procedures, some of which could 
include burn debridement, endoscopy, orthopedic injury reductions, and imaging scans. With a 
common goal of minimizing pain, anxiety, and trauma to the patient, the interdisciplinary team’s 
job is to increase the safety of the procedure for the physicians and the patient for it to be 
successful.  
 Nurses are a critical component in directing patient care due to our increased interactions 
with our patients. Nurses are a secondhand to the doctors as sometimes they are more in tune 
with the feelings, thoughts, and wishes of our patients. With the working relationship between 
nurses and physicians, this provides a great space to emphasize the importance of pain control 
while minimizing potential harmful effects involving both the respiratory and cardiovascular 
system alike. Nurses should encourage the implementation and relay the information of 
systematic reviews, meta-analyses, and the most current up to date evidence there is to best suit 
our patients. A meta-analysis would be pivotal in being able to assess not only the benefits of 
ketofol versus propofol, but patient satisfaction between the two, and the occurrence of these 
potentially fatal outcomes that may need required interventions. From there, nurses can then 
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advocate for their patients based on the interpretation of the data that is being presented with the 
knowledge in mind of the best evidence based practices. 
Conclusion of Evidence 
 Overall, while there was great evidence, clinical trials, and systematic reviews to look 
over, there is still a good amount of research left to be done in the realm of procedural sedation 
and analgesia. While the goal of this evidence was to identify which of these anesthetic options 
best reduces respiratory complications, other factors were also assessed. The respiratory outcome 
was the primary determinant for which anesthetic would be most ideal for procedural sedation, 
but studies also took a look at cardiovascular complications, recovery time, patient satisfaction, 
and nausea and vomiting. There were some gaps and potential confounding variables when it 
came to all of the evidence. Some patients were administered a pre-procedural medication and 
prophylactic oxygen which could have contributed to a different overall effect when patients 
were administered ketofol or propofol. It was also difficult to find studies that just included 
adults ages 18 and over, as some focused on younger kids or teenagers.  
When comparing the data collected from the clinical trials, meta-analyses, and systematic 
reviews, Miner et al. and Ferguson et al. found that there was no statistical difference in the 
adverse respiratory events between propofol and ketofol groups alike. However, in the reviews 
of Yan et al. and Jalili et al., these teams of researchers did find evidence to be statistically 
significant of ketofol having a lower number of adverse respiratory events. While all of these 
studies show a high level of understanding and provide quality evidence, there is no consistent 
evidence to show that propofol or ketofol is better than the other for procedural sedation. While 
both of these anesthetics have benefits and negative side effects, procedural sedation and 
anesthesia usually requires combinations of multiple agents to reach desired effects of analgesia 
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plus anxiolysis (Deady et al., 2007), which is why I think the benefits of the combined effects of 
ketamine and propofol outweighs the effects of propofol alone.  
By following the acronym SOAPME (suction, oxygen, airway, pharmacy, monitors, and 
equipment), this method can be implemented and encouraged by nurses and physicians alike to 
ensure patient monitoring and quality care is followed entirely (Deady et al., 2007). In 
combination with physicians, nurses are crucial in implementing the best and most helpful pain 
management and anxiety helpful options for care whether it is during an emergency visit, a 
longer stay, or more importantly during procedural sedation.  
While the choice of the medications used is ultimately left up to the physicians and 
anesthesiologists, it is crucial to look at an individual’s health history to choose the anesthetic 
drug that will offer the best health outcome and surgical experience while combating any 
potential negative side effects. Patient care is of the utmost importance in any situation, 
especially during an event requiring anesthesia. With the help of a great interdisciplinary team 
and the best evidence based practices, we can help our patients experience successful outcomes 







KETOFOL VERSUS PROPOFOL IN PROCEDURAL SEDATION 14 
 
References 
Adams, D., Dervay, K., Alexander, E., & Susla , G. (2012, October 1). Pharmacology of 
Procedural Sedation. Retrieved from https://aacnjournals.org/aacnacconline/article-
abstract/23/4/349/14629/Pharmacology-of-Procedural-Sedation?redirectedFrom=fulltext 
Andolfatto, G., & Willman, E. (2011). A Prospective Case Series of Single-syringe Ketamine-
Propofol (Ketofol) for Emergency Department Procedural Sedation and Analgesia in 
Adults. Academic Emergency Medicine, 18(3), 237–245. doi: 10.1111/j.1553-
2712.2011.01010.x 
Anesthesia. (2020, March 11). Retrieved from https://www.nigms.nih.gov/education/fact-
sheets/Pages/anesthesia.aspx 
Deady, K. A., Smith, K. M., & Kuhn, R. J. (2007). Clinical Pearls for Procedural Sedation. 
Orthopedics, 30(7), 527–531. doi: 10.3928/01477447-20070701-04 
Ferguson, I., Bell, A., Treston, G., New, L., Ding, M., & Holdgate, A. (2016, November). 
Propofol or Ketofol for Procedural Sedation and Analgesia in Emergency Medicine-The 
POKER Study: A Randomized Double-Blind Clinical Trial. Retrieved from 
https://www.ncbi.nlm.nih.gov/pubmed/27460905 
Ghojazadeh, M., Sanaie, S., Paknezhad, S. P., Faghih, S.-S., & Soleimanpour, H. (2019). Using 
Ketamine and Propofol for Procedural Sedation of Adults in the Emergency Department: 
A Systematic Review and Meta-Analysis. Advanced Pharmaceutical Bulletin, 9(1), 5–11. 
doi: 10.15171/apb.2019.002 
KETOFOL VERSUS PROPOFOL IN PROCEDURAL SEDATION 15 
 
History of Anesthesia. (n.d.). Retrieved from http://www.anzca.edu.au/about-anzca/history-and-
heritage/history-of-anaesthesia 
Jalili, M., Bahreini, M., Doosti-Irani, A., Masoomi, R., Arbab, M., & Mirfazaelian, H. (2016, 
March). Ketamine-propofol combination (ketofol) vs propofol for procedural sedation 
and analgesia: systematic review and meta-analysis. Retrieved from 
https://www.ncbi.nlm.nih.gov/pubmed/26809929 
Kanaya, N., Hirata, N., Kurosawa, S., Nakayama, M., & Namiki, A. (2003, January 1). 
Differential Effects of Propofol and Sevoflurane on Heart Rate Variability. Retrieved 
from https://anesthesiology.pubs.asahq.org/article.aspx?articleid=2173902 
Miner, J. R., Moore, J. C., Austad, E. J., Plummer, D., Hubbard, L., & Gray, R. O. (2015, May). 
Randomized, double-blinded, clinical trial of propofol, 1:1 propofol/ketamine, and 4:1 
propofol/ketamine for deep procedural sedation in the emergency department. Retrieved 
from https://www.ncbi.nlm.nih.gov/pubmed/25441247 
Smith I, Monk TG, White PF, Ding Y. Propofol infusion during regional anesthesia: sedative, 
amnestic, and anxiolytic properties. Anesth Analg 1994;79:313–9. 
Weiss AJ, Wier LM, Stocks C, et al. Overview of Emergency Department Visits in the United 
States, 2011: Statistical Brief #174. 2014 Jun. In: Healthcare Cost and Utilization Project 
(HCUP) Statistical Briefs [Internet]. Rockville (MD): Agency for Healthcare Research 
and Quality (US); 2006 Feb-. Available from: 
https://www.ncbi.nlm.nih.gov/books/NBK235856/ 
Yan, J. W., McLeod, S. L., & Iansavitchene, A. (2015, September). Ketamine-Propofol Versus 
Propofol Alone for Procedural Sedation in the Emergency Department: A Systematic 
KETOFOL VERSUS PROPOFOL IN PROCEDURAL SEDATION 16 
 
Review and Meta-analysis. Retrieved from 
https://www.ncbi.nlm.nih.gov/pubmed/26292077 
Zanetti, G. (n.d.). Gamma-aminobutyric acid (GABA). Retrieved from 
http://www.chm.bris.ac.uk/motm/gaba/gabajm.htm 
 
 
 
 
 
